Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder

Introduction: Patients with Major depressive disorder (MDD) and Borderline personality disorder (BPD) show a poorer prognosis compared to patients without BPD. A potential contributor is the complexity of establishing a therapeutic alliance with patients with BPD. A potential underlying biological m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: figshare admin karger (2628495) (author)
Další autoři: Peysachov G. (22681778) (author), Tchizick A. (22681781) (author), Delgadillo J. (22681784) (author), Shamay-Tsoory S. (18322077) (author), Zilcha-Mano S. (14332140) (author)
Vydáno: 2025
Témata:
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
_version_ 1849927633735778304
author figshare admin karger (2628495)
author2 Peysachov G. (22681778)
Tchizick A. (22681781)
Delgadillo J. (22681784)
Shamay-Tsoory S. (18322077)
Zilcha-Mano S. (14332140)
author2_role author
author
author
author
author
author_facet figshare admin karger (2628495)
Peysachov G. (22681778)
Tchizick A. (22681781)
Delgadillo J. (22681784)
Shamay-Tsoory S. (18322077)
Zilcha-Mano S. (14332140)
author_role author
dc.creator.none.fl_str_mv figshare admin karger (2628495)
Peysachov G. (22681778)
Tchizick A. (22681781)
Delgadillo J. (22681784)
Shamay-Tsoory S. (18322077)
Zilcha-Mano S. (14332140)
dc.date.none.fl_str_mv 2025-11-25T12:55:12Z
dc.identifier.none.fl_str_mv 10.6084/m9.figshare.30706580.v1
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Material_for_Trait-like_and_State-like_Oxytocin_A_Biomarker_of_Alliance_in_Patients_with_Depression_and_Borderline_Personality_Disorder/30706580
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Medicine
Medicine
dc.title.none.fl_str_mv Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description Introduction: Patients with Major depressive disorder (MDD) and Borderline personality disorder (BPD) show a poorer prognosis compared to patients without BPD. A potential contributor is the complexity of establishing a therapeutic alliance with patients with BPD. A potential underlying biological mechanism is Oxytocin (OT), a hormone associated with social bonding and trust. The aim of this study was to assess whether the interaction between OT pre-session (session-level trait-like) and change in OT throughout session (state-like) in both patients and therapists predicts the therapeutic alliance in patients with MDD and varying severity of BPD. We hypothesized that patients with higher BPD severity would show a compensatory pattern, where increase in state-like OT would compensate for low session-level trait-like OT, resulting in a stronger alliance. We also explored this interplay in the therapists' OT. Method: Eighty-four patients from a randomized control trial were assessed for BPD severity prior to beginning 16 sessions of short-term psychotherapy. Both patients and therapists provided saliva samples pre- and post- sessions 4, 8, 12 and 16 for OT analysis. Alliance was measured post-session. A series of linear mixed-effects models was used to test the hypothesis. Results: Our hypothesis was partially confirmed. In patients with higher BPD severity, when therapists had low session-level trait-like OT, the more they increased in state-like OT, patients rated their alliance as stronger. However, this compensatory pattern did not emerge in patients. Conclusion: These findings demonstrate the potential importance of OT as a biomarker of therapeutic processes in patients with MDD and BPD.
eu_rights_str_mv openAccess
id Manara_f675e73e8c705a327296017c7d862ec7
identifier_str_mv 10.6084/m9.figshare.30706580.v1
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30706580
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorderfigshare admin karger (2628495)Peysachov G. (22681778)Tchizick A. (22681781)Delgadillo J. (22681784)Shamay-Tsoory S. (18322077)Zilcha-Mano S. (14332140)MedicineMedicineIntroduction: Patients with Major depressive disorder (MDD) and Borderline personality disorder (BPD) show a poorer prognosis compared to patients without BPD. A potential contributor is the complexity of establishing a therapeutic alliance with patients with BPD. A potential underlying biological mechanism is Oxytocin (OT), a hormone associated with social bonding and trust. The aim of this study was to assess whether the interaction between OT pre-session (session-level trait-like) and change in OT throughout session (state-like) in both patients and therapists predicts the therapeutic alliance in patients with MDD and varying severity of BPD. We hypothesized that patients with higher BPD severity would show a compensatory pattern, where increase in state-like OT would compensate for low session-level trait-like OT, resulting in a stronger alliance. We also explored this interplay in the therapists' OT. Method: Eighty-four patients from a randomized control trial were assessed for BPD severity prior to beginning 16 sessions of short-term psychotherapy. Both patients and therapists provided saliva samples pre- and post- sessions 4, 8, 12 and 16 for OT analysis. Alliance was measured post-session. A series of linear mixed-effects models was used to test the hypothesis. Results: Our hypothesis was partially confirmed. In patients with higher BPD severity, when therapists had low session-level trait-like OT, the more they increased in state-like OT, patients rated their alliance as stronger. However, this compensatory pattern did not emerge in patients. Conclusion: These findings demonstrate the potential importance of OT as a biomarker of therapeutic processes in patients with MDD and BPD.2025-11-25T12:55:12ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.6084/m9.figshare.30706580.v1https://figshare.com/articles/dataset/Supplementary_Material_for_Trait-like_and_State-like_Oxytocin_A_Biomarker_of_Alliance_in_Patients_with_Depression_and_Borderline_Personality_Disorder/30706580CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307065802025-11-25T12:55:12Z
spellingShingle Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
figshare admin karger (2628495)
Medicine
Medicine
status_str publishedVersion
title Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
title_full Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
title_fullStr Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
title_full_unstemmed Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
title_short Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
title_sort Supplementary Material for: Trait-like and State-like Oxytocin: A Biomarker of Alliance in Patients with Depression and Borderline Personality Disorder
topic Medicine
Medicine